Abiopharma

Johnson & Johnson unveils new data showing nipocalimab is the first and only investigational FcRn blocker with potential to reduce systemic lupus erythematosus (SLE) activity in a Phase 2 study

Elanco Animal Health Inc. - Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference

(90% Positive) Denali Therapeutics Inc. (DNLI) Announces Enrollment Update for year Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Edgewise Therapeutics - Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026

(99% Neutral) DARE BIOSCIENCE, INC. (DARE) Files Form 8-K

SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma

(90% Positive) Compass Therapeutics, Inc. (CMPX) Announces Enrollment Update for observed Due to Patient Enrollment Issues, Regulatory Process, Safety Review

Nortech Systems Names Andrew Walko Senior Vice President of Global Operations

(99% Neutral) NORTECH SYSTEMS INCORPORATED (NSYS) Files Form 8-K

(99% Neutral) EARTH SCIENCE TECH, INC. (ETST) Files Form 8-K

Thermo Fisher Scientific - Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer

Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026